EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrin α7 defines a profibrotic adipose stromal population targeted for nanoparticle PAI-1 gene silencing in obesity

Linda Mota, David Zhang, Yulieth Soto Ortiz, Federico Zertuche Gonzalez, Eunhee Chung, Caleb Dang, Achraf Noureddine, Eric M Brey, Maria A Gonzalez Porras

Molecular Therapy · 2026-11 · 34 (11) · 6358-6376

DOI: 10.1016/j.ymthe.2026.08.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026-11. Verfasst von Linda Mota und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, San Antonio, TX, USA. Hauptthemen laut MEDLINE: Integrin alpha Chains, Obesity, Nanoparticles, Stromal Cells. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, US Department of War.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity-associated metabolic dysfunction is driven not only by adipocyte expansion but also by pathological remodeling of adipose tissue mediated by distinct stromal cell subpopulations. However, the lack of strategies to selectively interrogate and therapeutically modulate these pathogenic cells has limited clinical progress. Here, we identify integrin α7 (ITGA7)-expressing adipose stromal cells (ASCs) as a proinflammatory and profibrotic population that contributes to adipose tissue dysfunction in obesity and introduce a targeted nanotherapy to selectively reprogram their inflammatory signaling. ITGA7high ASCs from obese white adipose tissue display a profibrotic, proinflammatory phenotype with impaired adipogenic capacity, exacerbated by inflammatory stress. To selectively target this subset, we engineered lipid-coated mesoporous silica nanoparticles functionalized with anti-ITGA7 antibodies, which exhibit preferential uptake by ITGA7high ASCs in vitro and in vivo. Leveraging this platform, we delivered small interfering RNA (siRNA) against plasminogen activator inhibitor-1 (PAI-1), a key regulator of obesity-associated inflammation and fibrosis. In obese mice, ITGA7-targeted siRNA nanotherapy selectively accumulates in white adipose tissue and effectively silences PAI-1 expression at both the tissue level and within ITGA7high ASCs. Together, these findings establish ITGA7 as a therapeutically accessible marker of pathogenic ASC and define a molecular therapy framework for cell-selective genetic intervention within stromal niches in obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Integrin alpha ChainsObesityNanoparticlesStromal CellsPlasminogen Activator Inhibitor 1Gene SilencingAdipose TissueAnimalsMiceRNA, Small InterferingHumansFibrosisAntigens, CD

Stichwörter der Autor:innen

ASCsITGA7LCMSNsPAI-1SERPINE1adipose stromal cellsfibrosisintegrin alpha 7lipid-coated mesoporous silica nanoparticlesobesitysiRNA deliverytargeted nanotherapy

Substanzen

Integrin alpha ChainsPlasminogen Activator Inhibitor 1RNA, Small Interferingintegrin alpha7Antigens, CD

Autor:innen und Institutionen

  • Department of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, San Antonio, TX, USA.
  • Department of Kinesiology, University of Texas at San Antonio, San Antonio, TX, USA.
  • Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, USA.
  • Department of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, San Antonio, TX, USA. Electronic address: maria.gonzalezporras@utsa.edu.

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • US Department of War
  • Max and Minnie Tomerlin Voelcker Fund

Zitieren

APA

Mota, L., Zhang, D., Soto Ortiz, Y., Zertuche Gonzalez, F., Chung, E., Dang, C., Noureddine, A., Brey, E. M., & Gonzalez Porras, M. A. (2026). Integrin α7 defines a profibrotic adipose stromal population targeted for nanoparticle PAI-1 gene silencing in obesity. Molecular Therapy, 34(11), 6358-6376. https://doi.org/10.1016/j.ymthe.2026.08.005

Vancouver

Mota L, Zhang D, Soto Ortiz Y, Zertuche Gonzalez F, Chung E, Dang C, et al. Integrin α7 defines a profibrotic adipose stromal population targeted for nanoparticle PAI-1 gene silencing in obesity. Molecular Therapy. 2026;34(11):6358-6376. doi:10.1016/j.ymthe.2026.08.005

BibTeX
@article{Mota2026,
  author = {Mota, Linda and Zhang, David and Soto Ortiz, Yulieth and Zertuche Gonzalez, Federico and Chung, Eunhee and Dang, Caleb and Noureddine, Achraf and Brey, Eric M and Gonzalez Porras, Maria A},
  title = {Integrin α7 defines a profibrotic adipose stromal population targeted for nanoparticle PAI-1 gene silencing in obesity},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {11},
  pages = {6358--6376},
  doi = {10.1016/j.ymthe.2026.08.005}
}
Kostenlos starten →